ALYSSA TAFT: Open Payments
NPI 1487138590 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,507 in 19 payments from 11 companies in 2025. Trend: 2023 $1,579 · 2024 $1,777 · 2025 $1,507
Speaker / faculty: $1,100Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $1,120 |
| ABBVIE INC. | 4 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Korlym, VRAYLAR, BREZTRI, REXULTI, TRELEGY ELLIPTA, NURTEC ODT, VERQUVO, Ozempic.
Industry payments across GA — which companies pay providers there.
